Acuitas Therapeutics Named Canada’s Top Small and Medium Employers in 2026
…work – closely, collaboratively, and with a shared commitment to scientific excellence,” said Tom Madden, CEO of Acuitas Therapeutics. “That foundation gives us the agility to respond quickly to complex…
2026 BBHIC Presentation
…& institutes • Foundations & NGOs We exclusively work in collaboration with partners and are focused on supporting our partners to bring their drug products to patients. Lipid nanoparticle (LNP)…
Ionizable lipid impurities drive RNA-lipid adduct formation in LNPs, impacting in vivo expression
…Who We Are OUR LNP TECHNOLOGY WHO WE WORK WITH HOW WE WORK • Cutting edge pharmaceutical & biotechnology companies • Leading academics in universities & institutes • Foundations &…
Acuitas Corporate Presentation
…• Cutting edge pharmaceutical & biotechnology companies • Leading academics in universities & institutes • Foundations & NGOs HOW WE WORK As a technology platform provider, we exclusively work in…
Advanced LNP Technology for Infectious Disease Vaccines
…These high potency LNP will provide a strong foundation for multivalent vaccines aimed at ensuring protection against multiple target strains and pathogens. Abstract Initial rounds of SAR modeling identified 12…
Advanced LNP Technology for Infectious Disease Vaccines
…These high potency LNP will provide a strong foundation for multivalent vaccines aimed at ensuring protection against multiple target strains and pathogens. Abstract Initial rounds of SAR modeling identified 12…
20261020 – WVC Europe – Next-Generation LNP – Advancing mRNA Vaccine Performance
…WORK WITH • Cutting edge pharmaceutical & biotechnology companies • Leading academics in universities & institutes • Foundations & NGOs HOW WE WORK As a technology platform provider, we exclusively…
Next Generation LNP Technology for Infectious Disease Vaccines_final
…LNP will provide a strong foundation for multivalent vaccines aimed at ensuring robust protection against multiple target strains and pathogens whilst maintaining favorable reactogenicity and tolerability. Next Generation Lipids Induce…
20260406 – Canada’s Top Small and Medium Employers
…of Acuitas Therapeutics. “That foundation gives us the agility to respond quickly to complex challenges and apply our LNP platform in ways that truly make a difference for our partners….